Satoru Miura

13PUBLICATIONS
67CO-AUTHORS
Predictive and prognostic markersCancer geneticsTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Feb 02, 2026
Analysis of Peripheral T Cell Profiling and Plasma Proteomics in Advanced NSCLC Patients Treated With Atezolizumab.

Atsuto Mouri, Hiroshi Kagamu, Koji Tamada

|Apr 16, 2025
Pragmatic Randomized Study of Afatinib Versus Chemotherapy for Patients With Non-Small Cell Lung Cancer With Uncommon Epidermal Growth Factor Receptor Mutations: ACHILLES/TORG1834.

Satoru Miura, Hiroshi Tanaka, Toshihiro Misumi

|Oct 11, 2024
Association between Immune-Related Adverse Events and Atezolizumab in Previously Treated Patients with Unresectable Advanced or Recurrent Non-Small Cell Lung Cancer.

Hidetoshi Hayashi, Makoto Nishio, Hiroaki Akamatsu

|Feb 15, 2024
Machine learning analysis of pathological images to predict 1-year progression-free survival of immunotherapy in patients with small-cell lung cancer.

Ryota Shibaki, Daichi Fujimoto, Tsukasa Nozawa

|Mar 03, 2023
Real-world therapeutic effectiveness of lorlatinib after alectinib in Japanese patients with ALK-positive non-small-cell lung cancer.

Yasushi Goto, Takehito Shukuya, Ai Murata

|Jan 08, 2023
Phase II Trial of the Combination of Alectinib with Bevacizumab in Alectinib Refractory ALK-Positive Nonsquamous Non-Small-Cell Lung Cancer (NLCTG1501).

Satoshi Watanabe, Kazuko Sakai, Naoya Matsumoto

Pageof 3

Frequent Collaborators

4 joint publications

Toshihiro Misumi

4 joint publications

Hidetoshi Hayashi

4 joint publications

Naoki Furuya

4 joint publications

Hiroaki Akamatsu